Chemoinformaics analysis of 2,3-Dehydro-4-oxo-beta-ionol
Molecular Weight | 206.285 | nRot | 2 |
Heavy Atom Molecular Weight | 188.141 | nRig | 9 |
Exact Molecular Weight | 206.131 | nRing | 1 |
Solubility: LogS | -2.317 | nHRing | 0 |
Solubility: LogP | 2.162 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 35.3163 |
nHD | 1 | BPOL | 18.9257 |
QED | 0.651 |
Synth | 4.051 |
Natural Product Likeliness | 2.597 |
NR-PPAR-gamma | 0.011 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.822 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.502 |
MDCK | 0.0000458 |
BBB | 0.256 |
PPB | 0.9106 |
VDSS | 1.462 |
FU | 0.0704 |
CYP1A2-inh | 0.052 |
CYP1A2-sub | 0.201 |
CYP2c19-inh | 0.104 |
CYP2c19-sub | 0.827 |
CYP2c9-inh | 0.045 |
CYP2c9-sub | 0.138 |
CYP2d6-inh | 0.042 |
CYP2d6-sub | 0.165 |
CYP3a4-inh | 0.102 |
CYP3a4-sub | 0.63 |
CL | 4.815 |
T12 | 0.509 |
hERG | 0.015 |
Ames | 0.033 |
ROA | 0.758 |
SkinSen | 0.932 |
Carcinogencity | 0.892 |
EI | 0.59 |
Respiratory | 0.973 |
NR-Aromatase | 0.007 |
Antiviral | Yes |
Prediction | 0.619915 |